BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 12970042)

  • 1. Alveolar-capillary membrane dysfunction in heart failure: evidence of a pathophysiologic role.
    Guazzi M
    Chest; 2003 Sep; 124(3):1090-102. PubMed ID: 12970042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced alveolar-capillary membrane diffusing capacity in chronic heart failure. Its pathophysiological relevance and relationship to exercise performance.
    Puri S; Baker BL; Dutka DP; Oakley CM; Hughes JM; Cleland JG
    Circulation; 1995 Jun; 91(11):2769-74. PubMed ID: 7758183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alveolar-capillary membrane dysfunction in chronic heart failure: pathophysiology and therapeutic implications.
    Guazzi M
    Clin Sci (Lond); 2000 Jun; 98(6):633-41. PubMed ID: 10814599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alveolar gas diffusion abnormalities in heart failure.
    Guazzi M
    J Card Fail; 2008 Oct; 14(8):695-702. PubMed ID: 18926442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of alveolar-capillary sodium handling as a mechanism of protection of gas transfer by enalapril, and not by losartan, in chronic heart failure.
    Guazzi M; Agostoni P; Guazzi MD
    J Am Coll Cardiol; 2001 Feb; 37(2):398-406. PubMed ID: 11216953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-converting enzyme inhibition restores the diffusing capacity for carbon monoxide in patients with chronic heart failure by improving the molecular diffusion across the alveolar capillary membrane.
    Guazzi M; Agostoni P
    Clin Sci (Lond); 1999 Jan; 96(1):17-22. PubMed ID: 9857102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Alveolar-capillary dysfunction in heart failure].
    De Vita S; Guazzi M; Oreglia J; Guazzi MD
    Ital Heart J Suppl; 2002 Oct; 3(10):1022-6. PubMed ID: 12478828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of alveolar-capillary membrane diffusing capacity with enalapril in chronic heart failure and counteracting effect of aspirin.
    Guazzi M; Marenzi G; Alimento M; Contini M; Agostoni P
    Circulation; 1997 Apr; 95(7):1930-6. PubMed ID: 9107182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gas diffusion and alveolar-capillary unit in chronic heart failure.
    Agostoni P; Bussotti M; Cattadori G; Margutti E; Contini M; Muratori M; Marenzi G; Fiorentini C
    Eur Heart J; 2006 Nov; 27(21):2538-43. PubMed ID: 17028107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial dysfunction and lung capillary injury in cardiovascular diseases.
    Guazzi M; Phillips SA; Arena R; Lavie CJ
    Prog Cardiovasc Dis; 2015; 57(5):454-62. PubMed ID: 25446556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impedance to gas transfer across the alveolar-capillary membrane in chronic cardiac failure.
    Guazzi M
    Ital Heart J; 2000 Mar; 1(3):169-73. PubMed ID: 10806983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes worsens pulmonary diffusion in heart failure, and insulin counteracts this effect.
    Guazzi M; Brambilla R; De Vita S; Guazzi MD
    Am J Respir Crit Care Med; 2002 Oct; 166(7):978-82. PubMed ID: 12359657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffusing capacity of the lung for carbon monoxide.
    MacIntyre NR
    Respir Care Clin N Am; 1997 Jun; 3(2):221-33. PubMed ID: 9390909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The alveolar to arterial oxygen partial pressure difference is associated with pulmonary diffusing capacity in heart failure patients.
    Morosin M; Vignati C; Novi A; Salvioni E; Veglia F; Alimento M; Merli G; Sciomer S; Sinagra G; Agostoni P
    Respir Physiol Neurobiol; 2016 Nov; 233():1-6. PubMed ID: 27374970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating plasma surfactant protein type B as biological marker of alveolar-capillary barrier damage in chronic heart failure.
    Magrì D; Brioschi M; Banfi C; Schmid JP; Palermo P; Contini M; Apostolo A; Bussotti M; Tremoli E; Sciomer S; Cattadori G; Fiorentini C; Agostoni P
    Circ Heart Fail; 2009 May; 2(3):175-80. PubMed ID: 19808337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sildenafil improves the alveolar-capillary function in heart failure patients.
    Bussotti M; Montorsi P; Amato M; Magini A; Baldassarre D; Tantardini F; Veglia F; Agostoni P
    Int J Cardiol; 2008 May; 126(1):68-72. PubMed ID: 17490765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased alveolar/capillary membrane resistance to gas transfer in patients with chronic heart failure.
    Puri S; Baker BL; Oakley CM; Hughes JM; Cleland JG
    Br Heart J; 1994 Aug; 72(2):140-4. PubMed ID: 7917686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary membrane diffusing capacity and capillary blood volume measured during exercise from nitric oxide uptake.
    Tamhane RM; Johnson RL; Hsia CC
    Chest; 2001 Dec; 120(6):1850-6. PubMed ID: 11742912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impeded alveolar-capillary gas transfer with saline infusion in heart failure.
    Guazzi M; Agostoni P; Bussotti M; Guazzi MD
    Hypertension; 1999 Dec; 34(6):1202-7. PubMed ID: 10601119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced rate of alveolar-capillary recruitment and fall of pulmonary diffusing capacity during exercise in patients with heart failure.
    Olson LJ; Snyder EM; Beck KC; Johnson BD
    J Card Fail; 2006 May; 12(4):299-306. PubMed ID: 16679264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.